RENATA MOEN: Open Payments
NPI 1417494840 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,968 in 166 payments from 27 companies in 2025. Trend: 2023 $2,963 · 2024 $3,705 · 2025 $3,968
Food & beverage: $3,878Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $722 |
| GlaxoSmithKline, LLC. | 22 | $469 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $224 |
| Actelion Pharmaceuticals US, Inc. | 8 | $212 |
| Merck Sharp & Dohme LLC | 9 | $212 |
| Amgen Inc. | 10 | $211 |
| Viatris Specialty LLC | 8 | $206 |
| Regeneron Healthcare Solutions, Inc. | 6 | $201 |
| ANI Pharmaceuticals, Inc. | 8 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $169 |
Products named: DUPIXENT, NUCALA, FASENRA, AIRSUPRA, TEZSPIRE, YUPELRI, OPSUMIT, PURIFIED CORTROPHIN GEL.
Industry payments across FL — which companies pay providers there.
